title: [Concurrent radiochemotherapy with 5-FU/mitomycin remains standard treatment for anal carcinoma. Long-term results of the phase III RTOG 98-11 trial].
authors.affiliation: Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway. carsten.nieder@nlsh.no
authors.forename: C
authors.initials: C
authors.lastname: Nieder
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001005:Anus Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D059248:Chemoradiotherapy / Q000379:methods*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D018572:Disease-Free Survival; D019583:Dose Fractionation, Radiation; D005472:Fluorouracil / Q000008:administration & dosage* / Q000009:adverse effects; D005500:Follow-Up Studies; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage* / Q000009:adverse effects*; D009367:Neoplasm Staging; D011879:Radiotherapy Dosage
chemical_list: D016685:Mitomycin; D002945:Cisplatin; D005472:Fluorouracil